Article

A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

2023-12-04

Abstract excerpt

<h4>Background</h4> In the advanced renal cell carcinoma (RCC) scenario there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint blockade. We conducted a retrospective study in order to develop and to validate a gene expression score for predicting clinical benefit to nivolumab in the advanced clear cell RCC setting and to characterize its underlying clinical, mole...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 65622027-5a64-5d72-af80-419f8e29e198
DOI: 10.1101/2023.12.03.23299342

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinomaDOI 10.1101/2023.12.03.23299342Read

A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma PatientsSemantic proximity Read

Development of a Prognostic Index for Clear Cell Renal Cell Carcinoma Using Machine Learning and Multi-omics Analysis to Enhance Clinical Outcomes and Drug SensitivitySemantic proximity Read

A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune InfiltrationSemantic proximity Read

Multi-omics features-based machine learning method improve immunotherapy response in clear cell renal cell carcinomaSemantic proximity Read

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell CarcinomaSemantic proximity Read

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell CarcinomaSemantic proximity Read

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell CarcinomaSemantic proximity Read

Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinomaSemantic proximity Read

Construction of a Prognostic Value Model in Papillary Renal Cell Carcinoma by Immune-Related GenesSemantic proximity Read

A promising prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genesSemantic proximity Read

A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.Semantic proximity Read

Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinomaSemantic proximity Read